San Francisco, CA, United States of America

Dennis M Fisher

This inventor holds 1 USPTO granted patent. Top assignee: Zalicus Pharmaceuticals, Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis M Fisher. Retrieved from https://idiyas.com/inventor/dennis-m-fisher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dennis M. Fisher: Innovator in Bioavailability Enhancement

Introduction

Dennis M. Fisher is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the bioavailability of certain compounds. His work is crucial for improving the effectiveness of medications.

Latest Patents

Dennis holds a patent for a "Method for increasing the bioavailability of benzhydryl piperazine containing compounds." This innovative method involves orally administering a compound of formula 1, or a pharmaceutically acceptable salt thereof, with food to increase its bioavailability. This advancement has the potential to improve patient outcomes by ensuring that medications are more effectively absorbed in the body.

Career Highlights

Dennis is currently associated with Zalicus Pharmaceuticals, Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in bioavailability is a key asset to the company and contributes to its mission of developing effective treatments.

Collaborations

Dennis collaborates with various professionals in the field, including his coworker Terrance P. Snutch. Their combined efforts aim to push the boundaries of pharmaceutical research and development.

Conclusion

Dennis M. Fisher is a dedicated inventor whose work in enhancing drug bioavailability is paving the way for more effective pharmaceutical treatments. His contributions are vital to the ongoing advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…